News & Updates
Filter by Specialty:
Cardiac manifestations after COVID-19 jabs: When do they arise and who are at risk?
Cardiac manifestations, such as acute myocardial infarction (AMI) and myocarditis, after vaccination for the coronavirus disease 2019 (COVID-19) are more common in men, according to a recent Singapore study. AMI is more likely to arise after the first shot, while myocarditis becomes more common after the second dose.
Cardiac manifestations after COVID-19 jabs: When do they arise and who are at risk?
06 Oct 2021Oteseconazole bests fluconazole for vaginal yeast infections
Oteseconazole (VT-1161), a novel investigational fungal CYP51 inhibitor, outdid fluconazole/placebo for managing acute and recurrent* vulvovaginal candidiasis (VVC), according to data from the phase III ultraVIOLET trial.
Oteseconazole bests fluconazole for vaginal yeast infections
05 Oct 2021COVID-19 in childhood cancer patients: What are the risk factors?
A large international database study has shown that children and adolescents with cancer have an elevated risk of severe or critical disease if infected with COVID-19. Furthermore, about half the patients receiving cancer therapy experienced modifications to their treatment regimens.
COVID-19 in childhood cancer patients: What are the risk factors?
04 Oct 2021Singapore lags in latent tuberculosis screening among HIV-positive individuals
Latent tuberculosis (TB) infection screening in Singapore, a nation with intermediate TB burden, appears to be below average among individuals who are HIV-positive, a study has revealed.
Singapore lags in latent tuberculosis screening among HIV-positive individuals
04 Oct 2021Acute abdomen, appendicitis may occur in children with COVID-19, MIS-C
Paediatric patients with COVID-19 or multisystem inflammatory syndrome in children (MIS-C) may develop acute abdomen, with or without appendicitis, a study in Latin America has found.
Acute abdomen, appendicitis may occur in children with COVID-19, MIS-C
04 Oct 2021COVID-19 vacc side effects: Fewer than expected?
A community-based study from the UK showed that the rate of systemic side effects is relatively low following vaccination with the BNT162b2 or ChAdOx1 nCoV-19 COVID-19 vaccines.